- Home
- CODI vs XNCR Comparison
CODI vs XNCR Comparison
Compare CODI & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CODI
- XNCR
- Stock Information
- Founded
- CODI 2005
- XNCR 1997
- Country
- CODI United States
- XNCR United States
- Employees
- CODI N/A
- XNCR N/A
- Industry
- CODI Home Furnishings
- XNCR Biotechnology: Pharmaceutical Preparations
- Sector
- CODI Consumer Discretionary
- XNCR Health Care
- Exchange
- CODI Nasdaq
- XNCR Nasdaq
- Market Cap
- CODI 480.0M
- XNCR 547.8M
- IPO Year
- CODI 2006
- XNCR 2013
- Fundamental
- Price
- CODI $7.28
- XNCR $8.55
- Analyst Decision
- CODI Buy
- XNCR Buy
- Analyst Count
- CODI 2
- XNCR 10
- Target Price
- CODI $26.00
- XNCR $23.33
- AVG Volume (30 Days)
- CODI 723.8K
- XNCR 752.4K
- Earning Date
- CODI 10-29-2025
- XNCR 11-05-2025
- Dividend Yield
- CODI 13.74%
- XNCR N/A
- EPS Growth
- CODI N/A
- XNCR N/A
- EPS
- CODI N/A
- XNCR N/A
- Revenue
- CODI $2,198,233,000.00
- XNCR $146,929,000.00
- Revenue This Year
- CODI $14.55
- XNCR $22.06
- Revenue Next Year
- CODI $8.54
- XNCR N/A
- P/E Ratio
- CODI N/A
- XNCR N/A
- Revenue Growth
- CODI 11.87
- XNCR N/A
- 52 Week Low
- CODI $5.98
- XNCR $6.92
- 52 Week High
- CODI $24.32
- XNCR $27.24
- Technical
- Relative Strength Index (RSI)
- CODI 52.52
- XNCR 57.48
- Support Level
- CODI $6.97
- XNCR $7.91
- Resistance Level
- CODI $7.81
- XNCR $8.69
- Average True Range (ATR)
- CODI 0.30
- XNCR 0.46
- MACD
- CODI -0.03
- XNCR 0.12
- Stochastic Oscillator
- CODI 36.90
- XNCR 83.04
About CODI D/B/A Compass Diversified Holdings Shares of Beneficial Interest
Compass Diversified Holdings is a diversified business conglomerate based in the United States having two groups: branded consumer business and industrial business. Branded consumer businesses are characterized as those businesses that capitalize on a valuable brand name in their respective market sector. It includes 5.11, Ergobaby, Liberty Safe, and Velocity Outdoor. Industrial businesses are characterized as those businesses that focus on manufacturing and selling particular products and industrial services within a specific market sector. The company has operations in the United States, Canada, Europe, Asia Pacific, and other International areas.
About XNCR Xencor Inc.
Xencor Inc a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab, and XmAb657. The group earns its revenue from collaboration agreements, product licensing agreements, and technology licensing agreements.